— Know what they know.
Not Investment Advice
Also trades as: 2877.HK (HKSE) · $vol 1M · CSWYY (OTC) · $vol 0M

CSWYF Earnings

China Shineway Pharmaceutical Group Limited
1W: +0.0% 1M: -6.9% 3M: -12.7% YTD: -12.7% 1Y: -12.7% 3Y: +16.9% 5Y: +3.9%
$1.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 63 · $758.4M mcap · 255M float · 0.0000% daily turnover
Last Earnings 2025-09-01
EPS
$0.11
▲ Beat +0.0%
Revenue
$231M
▲ Beat +0.0%
Next Earnings 2026-09-01

Estimate vs Actual

Earnings Surprise History

0/15
EPS Beats
2/15
Revenue Beats
0%
EPS Beat Rate
13%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-07-16 annual 2022-12-31 $0.13 $0.88 ▲ 0.75 $557,105,925 $3,817,280,516
2026-07-16 annual 2015-12-31 $0.12 $0.78 ▲ 0.66 $339,776,087 $2,204,441,770
2026-07-16 annual 2021-12-31 $0.15 $0.94 ▲ 0.79 $513,741,205 $3,270,404,588
2026-07-16 annual 2018-12-31 $0.09 $0.65 ▲ 0.56 $373,114,176 $2,565,203,491
2026-07-16 annual 2020-12-31 $0.08 $0.52 ▲ 0.44 $410,523,974 $2,678,853,670
2026-07-16 annual 2017-12-31 $0.07 $0.49 ▲ 0.42 $283,855,446 $1,870,108,617
2026-07-16 annual 2016-12-31 $0.09 $0.61 ▲ 0.52 $265,773,077 $1,846,931,529
2026-07-16 annual 2019-12-31 $0.10 $0.71 ▲ 0.61 $402,448,608 $2,773,353,848
2026-01-15 annual 2026-12-31 $— $1.09 ▲ 1.09 $— $3,032,383,036
2026-01-15 quarter 2024-09-30 $— $— — $— $5,613,680,000
2026-01-15 annual 2020-12-31 $— $0.08 ▲ 0.08 $— $410,523,974
2026-01-15 annual 2023-12-31 $— $1.02 ▲ 1.02 $— $4,645,717,041
2026-01-15 annual 2016-12-31 $— $0.09 ▲ 0.09 $— $265,773,077
2026-01-15 annual 2024-12-31 $— $1.22 ▲ 1.22 $— $4,411,427,418
2026-01-15 annual 2025-12-31 $— $1.08 ▲ 1.08 $— $3,133,288,890
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms